Formal statement on the forthcoming US Brainstorm trial
US Brainstorm Trial Statement
We have had many inquires regarding the BrainStorm Stem Cell Therapeutics Clinical Trial. BrainStorm is currently conducting a Phase IIa dose-escalating trial at the Hadassah Medical Center in Israel. We are working with Brainstorm on a planned Phase II study in the US. We hope to begin the trial in the second half of 2013. We will continue to follow the progress of the study in Israel and will keep our website and the NEALS website (www.alsconsortium.org) current on all new trials and start dates. Thank you for your interest.
U.S. News & World Report ranks Mass General the #1 hospital in America based on our quality of care, patient safety and reputation in 16 different specialties. Learn more about why we're #1.
Search the archive for previously published news articles, press releases and publications.
Departments and Centers at Mass General have a reputation for excellence in patient care. View a list of all departments.